Aids Dementia Complex
Last Posted: Aug 10, 2019
- Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection.
Hulgan Todd, et al. Journal of acquired immune deficiency syndromes (1999) 2019 4 (4) e95-e102
- Prevalence of MMP-8 gene polymorphisms in HIV-infected individuals and its association with HIV-associated neurocognitive disorder.
Singh HariOm, et al. Gene 2018 3 83-90
- Nuclear-Mitochondrial interactions influence susceptibility to HIV-associated neurocognitive impairment.
Smieszek S, et al. Mitochondrion 2018 7
- Promoter polymorphism MMP-1 (-1607 2G/1G) and MMP-3 (-1612 5A/6A) in development of HAND and modulation of pathogenesis of HAND.
Singh Hari Om, et al. Journal of biosciences 2017 9 (3) 481-490
- Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.
Jia Peilin, et al. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2017 4
- Genetic variation of MMP-2(-735 C?>?T) and MMP-9(-1562 C?>?T) gene in risk of development of HAND and severity of HAND.
Singh HariOm, et al. The journal of gene medicine 2016 8
- Impact of variants of MMP-7(-181A>G) gene in susceptibility to the development of HIV-associated neurocognitive disorder and its severity.
Singh HariOm, et al. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2016 8
- The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients.
Thames April D, et al. AIDS (London, England) 2015 7 (12) 1483-91
- Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.
Hulgan Todd, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015 6
- The longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning.
Levine Andrew J, et al. Journal of neurovirology 2014 6 (3) 243-57
- Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals.
Horn Anne, et al. Journal of neural transmission (Vienna, Austria : 1996) 2013 10 (10) 1411-9
- Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.
Morgan E E, et al. Journal of neurovirology 2013 4 (2) 150-6
- Cerebral ?-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ?4 carriers.
Soontornniyomkij Virawudh, et al. AIDS (London, England) 2012 11 (18) 2327-35
- Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women.
Morales Diana, et al. Journal of neurovirology 2012 12 (6) 488-502
- Relationship between apolipoprotein E4 genotype and white matter integrity in HIV-positive young adults in South Africa.
Hoare Jacqueline, et al. European archives of psychiatry and clinical neuroscience 2013 4 (3) 189-95
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.